Mersana Therapeutics, Inc. Made Headway

Tue 07 Apr 20 at 05:30 PM
Mersana Therapeutics, Inc. Made Headway

Mersana Therapeutics, Inc. (MRSN:NASDAQ) soared at $7.74, a gain of 43.9%. On Mon 06 Apr 20, MRSN:NASDAQ touched a New 2-Week Intraday Low of $5.18. The stock appeared on our News Catalysts scanner on Mon 30 Mar 20 at 07:24 PM in the 'BIOTECH' category. From Mon 23 Mar 20, the stock recorded 60.00% Up Days and 63.64% Green Days

The share price of the company has been moving sideways in recent weeks.

About Mersana Therapeutics, Inc. (MRSN:NASDAQ)

Mersana Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.